Ian is the Global Head of Biogen’s Biosimilars Unit and has more than 20 years of experience in the pharmaceutical industry. Prior to joining Biogen, Ian was at The Medicines Company for more than six years where his last role was Vice President and Head of Strategy and Business Development (EMEA). He has been a Global Franchise Leader and also the Vice President of Emerging Markets, where he set up operations in Brazil, Russia, India, China, Turkey, Poland and Middle East. 13 foundational years in commercial roles at Lilly, Ian has an MBA from Cranfield School of Management and a Bachelor of Engineering in Chemical and Process Engineering from Newcastle University. He is qualified as a Chartered Engineer and a certified Black belt in Lean Six Sigma.
Conference Keynote Speaker